CannabisNewsWire
Editorial Coverage: The 2018 U.S. Farm Bill
changes the way that CBD-based products are legally classified.
If the federal government permits the sale of cannabis-sourced
products online, established companies in the space could reap huge
rewards.
- The legalization of cannabis in Canada and some U.S. States has
demonstrated the latent demand for cannabis-based products.
- CBD is used to make numerous products and its potential uses
are growing.
- Research suggests that the market for CBD products could grow
to an estimated $22 billion over
the next four years.
There are likely big changes coming to the cannabis sector this
year. The 2018 U.S. Farm Bill took a major step towards the
normalization of cannabis-based products. Now that the bill has
passed into law, industrial hemp — and its byproduct CBD — will be
regulated by the U.S. Department of Agriculture.
SinglePoint Inc. (OTCQB: SING) (SING
Profile) is in a good position to take full advantage
of the changes in how CBD products are regulated. Major producers
such as Cronos Group Inc. (NASDAQ: CRON) (TSX:
CRON), Aphria Inc. (NYSE: APHA) (TSX:
APHA), Medical Marijuana Inc. (OTC: MJNA)
and OrganiGram Holdings Inc. (OTCQX: OGRMF) (TSX.V:
OGI) are also well-placed to expand into the CBD space,
but they may have to compete with a new class of growers.
There are more than 80 kinds of psychoactive compounds found in
the cannabis plant. While most people are familiar with THC, which
is used recreationally, CBD has shown promise in
treating everything from insomnia to serious neurological
disorders. The 2018 Farm Bill leaves THC-based products under the
jurisdiction of the Drug Enforcement Agency (DEA) but gives
jurisdiction of CBD-based products to the individual states. Most
industry experts predict that the popularity of these products will
explode as they become easily available due to the new
regulations.
To view an infographic of this editorial, click here.
A Waiting Market
Until now, CBD-based products were subject to federal
regulations, which made them impossible to distribute nationally.
They have been sold on a statewide basis in areas that allowed
their use, but anyone who dealt with these products was shut out of
the federal banking system because the crop — and its subsequent
products — were categorized as illegal at a federal level.
With the signing of the new legislation, that appears likely to
change. SinglePoint
(OTCQB: SING) is an established distributor of CBD
products and owns a decade-old web domain. Not only does the
company have experience with marketing and distributing CBD-based
products, it also has a background in payments processing.
CBD-based products are a new, largely unfamiliar area that may
pose challenges for new companies entering the space. Universal
standards for many CBD products have yet to be established or
identified, so having a positive market image will likely be a
significant benefit. Established companies with an existing client
base and a positive reputation may be in a better position to
leverage growth in the CBD sector. SinglePoint seems to fit this
criteria well.
Wide-Open Potential
There is a big difference between cannabis grown for medicinal
use and hemp that can now be used as a feedstock for CBD in the
United States. Major cannabis producers have a much higher cost of
production than hemp growers. With new changes that the 2018 Farm
Bill creates for hemp farmers, the price of CBD may fall substantially.
Instead of being cultivated in near-laboratory conditions,
industrial hemp is grown like any other commercial crop. Now that
CBD can be refined out of commercially produced hemp, it will be
difficult for anyone but U.S. hemp farmers to compete on price when
it comes to CBD.
Additionally, the 2018 Farm Bill normalizes the CBD economy at a
federal level. For the first time, hemp growers can use the banking
system, insure their crops, and even sell their future hemp
production via futures. Like any new market, it will take time for
the infrastructure to be developed, but early movers in the space
may have a significant advantage.
Big Changes for CBD
SinglePoint is in a unique position in the emerging CBD space.
As both an online marketer and payments processor, the company
looks to be in a strong position to help deliver CBD products to
their target markets. The company has a strong strategy to grow its presence in the CBD space.
Unlike many of the other publicly traded, cannabis-focused
companies, SinglePoint has no connection with cannabis plants and
cultivation, so the company should be able to take full advantage
of the recently passed 2018 Farm Bill.
It appears that there is no shortage of potential CBD-based
products. Currently, CBD is integrated into everything from lotions
and edibles to beer and oil. With the legalization of CBD widely
anticipated, research will almost certainly lead to additional
discoveries into CBD properties and benefits, as well as the
creation of new products targeting specific market segments.
The emerging CBD economy is also supported by the ability for
hemp producers to raise funds publicly. Much like the Canadian
cannabis producers that were able to expand quickly because of
their publicly traded equities, U.S. hemp producers can now go
public and leverage public interest in CBD to expand their
operations.
Changing Production Profiles
The 2018 Farm Bill is a huge positive for U.S.-based hemp
producers and CBD consumers.
One of the largest publicly traded cannabis producers available
to U.S. investors, Cronos Group (NASDAQ: CRON) (TSX:
CRON) owns two fully licensed cannabis producers in Canada
and has other interests spread around the world. The company has
maintained a multibillion-dollar valuation, despite some weakness
in the publicly traded cannabis sector. In addition to producing
cannabis in Canada, the company is involved in the distribution of
cannabis products in many of the markets in which it operates. In
the third quarter last year, the company reported increased
revenues by 186 percent and sold 213 percent more kilos of cannabis
than in the same time a year earlier.
Aphria (NYSE: APHA) (TSX: APHA) has grown its
presence in the Canadian cannabis space via acquisitions and
strategic investments and is one of the largest publicly traded
cannabis producers. The company made two high-profile acquisitions
last year, taking over Broken Coast Cannabis and buying Nuuvera, a
Canadian cannabis company with already-existing strategic exposure
to German and Italian markets. The vast majority of the company’s
production capacity for cannabis is concentrated in a single
facility, called Aphria One, which is located in Leamington,
Ontario.
Medical Marijuana (OTC: MJNA) has been
operating in the legal cannabis space for longer than most. The
company owns numerous subsidiaries, including HempMeds, Kannalife
and Kannaway. It also operates an international division, which has
developed a substantial presence in Brazil, where it was the first
company to introduce legal cannabis-based medicines to the
Brazilian market. The company also has a direct marketing structure
for cannabis products and appears to be well-placed to grow in the
emerging CBD market.
OrganiGram Holdings (OTCQX: OGRMF) (TSX.V: OGI)
is the parent company of Organigram Inc., one of the largest
licensed producers of cannabis in Canada. The company delivers
industry-leading yields from its growing facilities and is focused
on expanding in the Canadian market for recreational and medicinal
cannabis. Organigram developed a portfolio of brands for a variety
of uses, including The Edison Cannabis Company, Ankr Organics,
Trailer Blazer and Trailer Park Buds. In addition to growing
cannabis, OrganiGram also distributes it.
With the passage of the 2018 Farm Bill changing the legal status
of CBD, it is estimated that the CBD market will grow to be a $22
billion industry by 2022. SinglePoint has created a solid platform
to be a part of that industry.
For more information on SinglePoint, visit SinglePoint Inc.
(OTCQB: SING)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides
(1) access to our news aggregation and syndication servers, (2)
CannabisNewsBreaks that summarize
corporate news and information, (3) enhanced press release
services, (4) social media distribution and optimization services,
and (5) a full array of corporate communication solutions. As a
multifaceted financial news and content distribution company with
an extensive team of contributing journalists and writers, CNW is
uniquely positioned to best serve private and public companies that
desire to reach a wide audience of investors, consumers,
journalists and the general public. CNW has an ever-growing
distribution network of more than 5,000 key syndication outlets
across the country. By cutting through the overload of information
in today’s market, CNW brings its clients unparalleled visibility,
recognition and brand awareness. CNW is where news, content and
information converge.
Receive Text Alerts
from CannabisNewsWire: Text "Cannabis" to
21000
For more information please visit https://www.CannabisNewsWire.com and
or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the
CannabisNewsWire website applicable to all content provided by CNW,
wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article
and content set forth above. References to any issuer other than
the profiled issuer are intended solely to identify industry
participants and do not constitute an endorsement of any issuer and
do not constitute a comparison to the profiled issuer. The
commentary, views and opinions expressed in this release by CNW are
solely those of CNW. Readers of this Article and content agree that
they cannot and will not seek to hold liable CNW for any investment
decisions by their readers or subscribers. CNW is a news
dissemination and financial marketing solutions provider and is NOT
registered broker-dealers/analysts/investment advisers, hold no
investment licenses and may NOT sell, offer to sell or offer to buy
any security.
The Article and content related to the profiled company
represent the personal and subjective views of the Author, and are
subject to change at any time without notice. The information
provided in the Article and the content has been obtained from
sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all
such information. None of the Author, CNW, or any of their
respective affiliates, guarantee the accuracy or completeness of
any such information. This Article and content are not, and should
not be regarded as investment advice or as a recommendation
regarding any particular security or course of action; readers are
strongly urged to speak with their own investment advisor and
review all of the profiled issuer’s filings made with the
Securities and Exchange Commission before making any investment
decisions and should understand the risks associated with an
investment in the profiled issuer’s securities, including, but not
limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. “Forward-looking statements” describe future expectations,
plans, results, or strategies and are generally preceded by words
such as “may”, “future”, “plan” or “planned”, “will” or “should”,
“expected,” “anticipates”, “draft”, “eventually” or “projected”.
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company’s annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and CNW undertakes no
obligation to update such statements.
Source:
CannabisNewsWire
Contact:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
Medical Marijuana (PK) (USOTC:MJNA)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Medical Marijuana (PK) (USOTC:MJNA)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024
